Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-05T08:09:04.480Z Has data issue: false hasContentIssue false
  • English
  • Français

Bacteremia Due to Streptococcus agalactiae

Published online by Cambridge University Press:  21 June 2016

Marianna Mrazova ,
Vladimir Krcmery Jr. ,
Margareta Kacmarikova ,
Jadwiga Fargasova ,
Andrea Docze  and
Pavol Beno
Marianna Mrazova
Affiliation:
Postgraduate Medicine School, Bratislava, Slovak Republic
Vladimir Krcmery Jr.
Affiliation:
School of Health, Trnava University, Trnava, Slovak Republic
Margareta Kacmarikova
Affiliation:
School of Health, Trnava University, Trnava, Slovak Republic
Jadwiga Fargasova
Affiliation:
Department of Clinical Pharmacology, Kosice, Slovak Republic
Andrea Docze
Affiliation:
School of Health, Trnava University, Trnava, Slovak Republic
Pavol Beno
Affiliation:
School of Health, Trnava University, Trnava, Slovak Republic
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 26 , Issue 6 , June 2005 , pp. 509
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2005

References

1.Schuchat, A. Group G Streptococcus agalactiae. Lancet 1999;353:51–56.Google Scholar
2.Alós, JI, Aracil, B, Oteo, J, et al.High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M-phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. J Antimicrob Chemother 2000;45:605–609.Google Scholar